I’ve gotten a big pile of questions about the latest teaser pitch from Jeff Brown, who is now taking credit for the rise of the CRISPR stocks and sees another big surge coming. And for what it’s worth, he was one of the early newsletter guys promoting the three primary CRISPR stocks a few years […]
Articles
This article was originally published on November 5, 2018, we’re getting lots of questions so we’re popping it to the top of the page for you but it has not been updated or revised — the ad being covered appears to be almost identical to the ad that was running in the fall of 2018. […]
“This Wednesday, September 5 Tuesday, May 28, a group of scientists will take the stage at a prestigious medical conference… “And announce to the world the potential end of disease as we know it.” That’s the attention-getting part of Ray Blanco’s latest teaser ad for his FDA Trader newsletter that Gumshoe readers have been asking […]
Here’s a bit from the email that Matt McCall sent out introducing his lastest teaser ad: “When it comes down to it, there are really just three ways to get truly rich in the stock market. You can put thousands into the market every year, hold for decades, and retire with a fortune. You can […]
Matt McCall is pitching a “$200 into $1 million” stock idea as he tries to drum up subsribers for his NexGen Investor… and that sounds fun, right, owning a stock that goes to a million dollars per share? It probably won’t happen, of course, and I don’t know how many times it might have actually […]
This piece originally appeared as part of the Friday File for the Irregulars on July 28, but has now been unlocked for everyone. The company reported quarterly results about two weeks ago that were generally well received, and has otherwise gotten more positive press and analyst upgrades over the past month, and the shares are […]
The article below was originally published on November 27, 2017, when Jeff Brown’s ads promoting the “God Key” started to show up in our inboxes. It has not been updated or revised, but the new versions of the ad from Brown are very similar to the ones we covered in November, including the description of […]
Jason Stutman has a teaser pitch going around for his Technology & Opportunity newsletter (currently $99), and the bait for us is that he’s promising a company that will get you rich as Monsanto dies. Lots of folks have a deep hatred for Monsanto, of course, both because of anti-GMO fear and Roundup resistance/overuse/drift/cancer risk […]
Fear Of Missing Out is such a big deal that it gets its own acronym in my book (FOMO — and a clever FOMO-fueling website here), and it drives investors to take huge chances just so they don’t have to worry about missing a chance at stupendous gains. That’s what many newsletter ads use to […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
$GERN Going to look into the Geron Corp you mentioned, their shares took a huge drop last month, maybe a buying opportun...
$GERN np - Totally agree with Hedy1234. 9663 GERN, seems about once a year they say something; share price pops for a...
$GERN Dear Fr. KSS, i wanted to bring the attention to this company Geron Corp. I was wondering if you knew about it an...
pattaro $AUPH FBR's Chris Meekins says the potential for tax reform and FDA policy changes could stoke biotech M&A ...
Reader JZ wrote in requesting some guidance and coverage regarding Geron $GERN, a once-promising biotech that has underp...
$CUR Alan, Yes, I expect CUR to trade back to its pre-split AND pre-patent grant announcement price range (it's tra...
Interesting perspective on why Johnson and Johnson should purchase TransEnterix (TRXC) and Geron (GERN). http://www.f...
Yeah, Sears is a bit of a hypster. But he was the first doctor to admisister and promote TA-65, which, if you do the re...
$GERN Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes ht...
Disclosure, long Geron (GERN), which I believe is a good speculative investment and has an excellent chance of getting i...
$GERN Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Off...
Don't know if this makes a difference, but $GERN 's company name is GERON, not Genron. The fool.com article never said w...
$KBIO KalaBios Rallies Again- KalaBios Pharmaceuticals (KBIO) shares surged once again on Friday, posting gains of more...
I am in possession of one of the original gems, Geron Corp (GERN) which was supposed to have already by now given us a...
Fisherofmen: This new study will rattle Geron and imetelstat somewhat. http://www.nature.com/leu/journal/v27/n6/pdf/l...
It's been a while since I have looked in on it, and imetelstat has had some controversy. Let me look into it. May be ton...
Doc or Glenn, have y'all heard about Geron Corporation (GERN). They appeared to be a one drug (Imetelstat) company with...
Sorry for typo Geron not Genron. Cheers,Glenn...
To Booyah and others interested in Geron [GERN]: There was a great article on the Motley Fool website dated July 4, ...
Hey Tim, I've never heard of StemCells, but I do know Asterias and I did hear about them getting this money. Asterias ...
An article in SF Chronicle about stem cell therapies, and funding from the state of CA's pocketbook - $3bn set aside to ...
Elliot: the insider buying is a good point about Biotime, and yes if you are in I would stay in. I think it is an opport...
Doctor KSS, Thank you for spending some time on this one. I realize they are keeping things mysterious here, which coul...
With all of the talk about cancer, I am surprised there has been no discussion of Geron (perhaps there has been some and...
Thank you for the insight. I was searching other sources to find out why Geron was rising recently, but I was unaware of...
Travis, Does the Thinkolator have anything on the "Phoenix Event" that is offered as a free report as offered for a sub...
Welll, you dabble in the Gumshoe's business and you don't necessarily get it right. I thought that I had outsmarted Pa...
Wow...lots of off-point whining is right-sheesh. Marksman, necessity is the mother of invention-no need for population c...
Travis, You mentioned a second company Cox was intimating about. Could be Geron, as I just read an article by Cox for Sm...
Good comments. Thanks I've had Geron and PSTI for a while, and they are both up a little. I was looking at Bioti...